Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Adjuvant Chemotherapy for Stage II/III Breast Cancer
NCT00002679Phase 2Completed
- Sponsor
- Yale University
- Start
- Feb 1994
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in breast cancer, sponsored by Yale University. Primary endpoint: Efficacy of Sequential Adjuvant Chemotherapy. Started Feb 1994; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002679.